A common molecular feature identified is the increased BCR signaling in a significant fraction of DLBCL patients, ABC-DLBCL by cell-of-origin scheme and BCR-DLBCL by consensus clustering scheme. Here, BCR is linked to diffuse large B-cell lymphoma.